PIMJS
VRTX icon

PKO Investment Management Joint-Stock’s Vertex Pharmaceuticals VRTX Stock Holding History

PKO Investment Management Joint-Stock’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.49M Buy
11,050
+50
+0.5% +$22.2K 0.4% 58
2026
Q1 		$4.91M Sell
11,000
-200
-2% -$93.3K 0.41% 55
2025
Q4 		$5.08M Sell
11,200
-300
-3% -$129K 0.41% 55
2025
Q3 		$4.5M Sell
11,500
-2,000
-15% -$836K 0.38% 56
2025
Q2 		$6.01M Buy
13,500
+11,700
+650% +$5.39M 0.65% 39
2025
Q1 		$873K Sell
1,800
-5,800
-76% -$2.7M 0.1% 134
2024
Q4 		$3.06M Buy
7,600
+5,800
+322% +$2.69M 0.38% 54
2024
Q3 		$837K Buy
1,800
+800
+80% +$384K 0.1% 121
2024
Q2 		$469K Sell
1,000
-4,000
-80% -$1.74M 0.06% 147
2024
Q1 		$2.1M Hold
5,000
– – 0.25% 71
2023
Q4 		$2.03M Buy
+5,000
New +$1.85M 0.25% 64
2023
Q2 		– Sell
-2,000
Closed -$630K – 149
2023
Q1 		$630K Buy
2,000
+800
+67% +$240K 0.08% 123
2022
Q4 		$347K Hold
1,200
– – 0.05% 125
2022
Q3 		$347K Hold
1,200
– – 0.06% 123
2022
Q2 		$338K Sell
1,200
-1,300
-52% -$348K 0.05% 116
2022
Q1 		$652K Sell
2,500
-4,500
-64% -$1.07M 0.08% 103
2021
Q4 		$1.54M Buy
+7,000
New +$1.36M 0.17% 85

Other funds holding VRTX

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

PKO Investment Management Joint-Stock's VRTX Position: Q2 2026 in Review

PKO Investment Management Joint-Stock increased its Vertex Pharmaceuticals (VRTX) stake by 0.45% in Q2 2026, buying an estimated $22.2K and bringing the position to 11,050 shares worth $5.49M. The position accounts for 0.4% of the portfolio, ranked #58.

PKO Investment Management Joint-Stock first reported a position in VRTX in Q4 2021 and has held it in 17 quarters since. The position peaked at $6.01M in Q2 2025. 945 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • PKO Investment Management Joint-Stock held 11,050 shares of Vertex Pharmaceuticals worth $5.49M as of Q2 2026.
  • PKO Investment Management Joint-Stock bought 50 Vertex Pharmaceuticals shares in Q2 2026, an estimated $22.2K.
  • Vertex Pharmaceuticals made up 0.4% of PKO Investment Management Joint-Stock's portfolio in Q2 2026, its #58 holding.
  • PKO Investment Management Joint-Stock first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 17 quarters since.
  • PKO Investment Management Joint-Stock's Vertex Pharmaceuticals position peaked at $6.01M in Q2 2025.
  • 945 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on PKO Investment Management Joint-Stock's 13F filing for Q2 2026, filed 20 Jul 2026.